Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02446405
Brief Title: Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET)

First Submitted : May 4, 2015
First Submitted that Met QC Criteria : May 13, 2015
First Posted : May 18, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 1, 2018
Last Update Posted : May 3, 2018